-
Technology/Science
[JW R&D] Installed ‘No. 1’ Blood Irradiator SANGRAY in Korea
2021-02-11 -
Technology/Science
[JW R&D] JW Leading the Dream of Completely Conquering Atopic Dermatitis
2021-03-09 -
Technology/Science
[JW R&D] JW starts up developing ‘innovative infusion solution plant facility’ jointly with public a
2021-03-09
-
Technology/Science
[JW R&D] JW, ‘Receiving Attention’ as a Leader of Innovative New Drugs (First-in-Class)
2021-03-09 -
Technology/Science
[JW R&D] Renal Anemia Treatment of JW Pharmaceutical, Achieved New Drug Approval in Japan
2021-03-09 -
Technology/Science
[JW R&D]JW, Making a New History of Developing Innovative New Drugs (first-in-class) in Korea
2021-03-09
PR more
- JW Pharmaceutical’s C&C Research Laboratories Selected for National New Drug Development Project for Prostate Cancer Treatment
- JW Pharmaceutical Receives IND Approval for STAT3-Targeted Anticancer Drug ‘JW2286’
- JW Pharmaceutical Demonstrates Superior Hair Follicle Formation and Hair Growth of ‘JW0061’ Compared to Existing Hair Loss Treatments
- JW Pharmaceutical Presents Preclinical Results for Hair Loss Treatment ‘JW0061’ at the Society of Investigative Dermatology
- JW Pharmaceutical, U.S. DSMB Recommends Continuation of Global Phase 3 Trial for Gout Treatment 'Epaminurad'
- JW Pharmaceutical's Gout Treatment 'Epaminurad' Receives Phase 3 Clinical Trial Approval in Malaysia
JW of the day